BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs2300478
,
BRAF
,
calcium channel activity
,
Arthritis
,
Leukocyte
,
Alcohol
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
BARD1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Nipple cross-section
Conjunctiva
Thymus gland
Penis
Pharyngeal mucosa
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
MCF-10F breast epithelial cells treated with BPA
MCF-10F breast epithelial cells in response to the xenoestrogen bisphenol A
Explore Curated Studies Results
Literature
Most Relevant Literature
Aberrant Zip14 expression in muscle is associated with cachexia in a Bard1-deficient mouse model of …
BARD1 mediates TGF-β signaling in pulmonary fibrosis.
BRCA1/BARD1 is a nucleosome reader and writer.
BARD1 is an ATPase activating protein for OLA1.
CRL4-DCAF8L2 E3 ligase promotes ubiquitination and degradation of BARD1.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients Wi…
Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations
Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer
Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumor…
A Study to Evaluate Rucaparib in Patients With Solid Tumors and With Deleterious Mutations in HRR Ge…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ